Method Evaluation-A Practical Guide

The Immunoassay Handbook

Volumn , Issue , 2013, Pages 395-402

  Sheehan, Chris ^a   He, Jianwen ^b   Smith, Mari ^a  

^a BioMerieux Ltd ^*

^b BIOMÉRIEUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884038229     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-08-097037-0.00026-9     Document Type: Chapter

References (18)

1. Armbruster D.A., Pry T. Limit of blank, limit of detection and limit of quantitation. Clin. Biochem. Rev. 2008, (Suppl. 1):S49-S52.
2. CLSI Evaluation of Precision Performance of Quantitative Measurement Methods; Approved Guideline 2004, CLSI, Wayne, Pennsylvania, P05-A2. 2nd edn.
3. CLSI Expression of Measurement Uncertainty in Laboratory Medicine: Approved Guideline, C51-A 2012, CLSI, Wayne, Pennsylvania.
4. CLSI Evaluation of the Linearity of Quantitative Measurement Procedures: A Statistical Approach; Approved Guideline, EP06-A 2003, CLSI, Wayne, Pennsylvania.
5. CLSI Interference Testing in Clinical Chemistry; Approved Guideline 2005, CLSI, Wayne, Pennsylvania, EP07-A2. 2nd edn.
6. CLSI Method Comparison and Bias Estimation Using Patient Samples; Approved Guideline 2010, CLSI, Wayne, Pennsylvania, EP09-A2-IR. 2nd edn, (Interim Revision).CLSI
7. CLSI Preliminary Evaluation of Quantitative Clinical Laboratory Measurement Procedures; Approved Guideline 2006, CLSI, Wayne, Pennsylvania, EP10-A3. 3rd edn.
8. CLSI Statistical Quality Control for Quantitative Measurement Procedures: Principles and Definitions; Approved Guideline 2006, CLSI, Wayne, Pennsylvania, C24-A3. 3rd edn.
9. CLSI User Protocol for Evaluation of Qualitative Test Performance; Approved Guideline 2008, CLSI, Wayne, Pennsylvania, EP12-A2. 2nd edn.
10. CLSI User Verification of Performance for Precision and Trueness; Approved Guideline 2006, CLSI, Wayne, Pennsylvania, EP15-A2. 2nd edn.
11. Cummings J., Ward T.H., Greystoke A., Ranson M., Dive C. Biomarker method validation in anticancer drug development. Br. J. Pharmacol. 2008, 153:646-656.
12. Ekins R.P. The precision profile; its use in assay design, assessment and quality control. Immunoassays for Clinical Chemistry 1983, Churchill Livingstone, London. 2nd edn. W.M. Hunter, J.E.T. Corrie (Eds.).
13. Feldkamp C.S., Smith S.W. Practical guide to immunoassay method evaluation. Immunoassay, a Practical Guide 1987, 49-95. Academic Press, Orlando. D.W. Chan, M.T. Perlstein (Eds.).
14. Hopley L., van Schalkwyk J. The magnificent ROC http://www.anaesthetist.com/mnm/stats/roc.
15. Jin H., Zangar R.C. Antibody microarrays for high-throughput, multianalyte analysis. Cancer Biomark. 2010, 6:281-290.
16. Marchiò C., Dowsett M., Reis-Filho J.S. Revisiting the technical validation of tumour biomarker assays: how to open a Pandora's box. BMC Med. 2011, 9:41.
17. Khan M.N., Findlay J.W. Ligand-Binding Assays: Development, Validation, and Implementation in the Drug Development Arena 2009, Wiley-blackwell, Oxford.
18. Zweig M.H., Robertson E.H. Clinical validation of immunoassays: a well-designed approach to a clinical study. Immunoassay, a Practical Guide 1987, 97-127. Academic Press, Orlando. D.W. Chan, M.T. Perlstein (Eds.).